
SBI Contra Fund-Reg(G)
- Equity
- Contra
- Very High Risk
Fund Overview
- Assets Under Management (AUM)
- ₹0.00 Cr
- Expense Ratio
- 1.48%
- Riskometer
- Very High
- Category
- Contra
- Asset Type
- Equity
- Benchmark
- BSE SENSEX - TRI
- SIP
- Available
- Switch
- Available
- Inception Date
- 3 May 2018
- ISIN
- INF200K01362
- Scheme Code
- 036G
- Fund Scheme ID
- 3151
Thinking of investing in mutual funds?
Discover a simpler way to begin investing with Indipe.
Performance & Returns
Calculate SIP ReturnsReturns by period
| Period | Trailing Return | Absolute Return | Annualised Return | CAGR |
|---|---|---|---|---|
| 1 Month | -1.49% | -2.19% | -17.51% | -21.25% |
| 3 Months | 2.31% | 1.86% | 9.15% | 10.01% |
| 6 Months | -0.27% | -1.23% | -0.53% | -4.47% |
| 1 Year | -0.37% | -1.02% | -0.37% | -0.58% |
| 3 Years | 10.79% | 34.03% | 12.00% | 11.09% |
| 5 Years | 15.01% | 99.04% | 20.26% | 15.02% |
| Since Inception | 18.25% | 9377.29% | 347.06% | 18.25% |
Past performance is not indicative of future returns.
Portfolio
Portfolio breakdown is not available
This fund has no published asset or sector allocation yet.
Holdings
Overview of fund allocations across sectors and securities
Holdings are not available
This fund has no published sector, stock or debt holdings yet.
About
Fund Manager(s)
Mr. Dinesh Balachandran
Launch Date
3 May 2018
Benchmark
BSE SENSEX - TRI
Objective
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz. Information Technology,Pharmaceuticals, FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.
RISKOMETER
The riskometer indicates the level of risk associated with the fund based on historical data and portfolio composition.
Exit Load, Stamp Duty and Tax Implication
- Exit load
- 0.25% on or before 30D, 0.10% after 30D but before 90D, Nil after 90D
- Stamp duty on investment: 0.005% (from July 1st, 2020)
- from July 1st 2020
- Tax implication
- --